Alnylam Pharmace. buy WatchMen
Start price
16.10.19
/
50%
€73.50
Target price
09.02.20
-
Performance (%)
54.50%
End price
09.02.20
€113.56
Summary
This prediction ended on 09.02.20 with a price of €113.56. With a performance of 54.50% the BUY prediction by WatchMen was a big success. WatchMen has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Alnylam Pharmace. | 7.770% | 7.770% | -2.266% | 58.621% |
| iShares Core DAX® | 4,57 % | 4,14 % | 7,35 % | 57,58 % |
| iShares Nasdaq 100 | 1,83 % | -1,64 % | 33,64 % | 88,08 % |
| iShares Nikkei 225® | -0,29 % | 2,47 % | 60,45 % | 76,67 % |
| iShares S&P 500 | 2,23 % | 0,71 % | 24,13 % | 66,11 % |
Comments by WatchMen for this prediction
In the thread Alnylam Pharmace. diskutieren
Buy Alnylam Pharmace.